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Abstract 
Objective: Many breast cancer survivors feel constrained in discussing their cancer experience 
with others.  Limited evidence suggests that social constraints (e.g., avoidance, criticism) from 
loved ones may negatively impact breast cancer survivors’ global health, but research has yet to 
examine relationships between social constraints and common physical symptoms.  Informed by 
social cognitive processing theory, this study examined whether perceived social constraints 
from partners and health care providers (HCPs) were associated with fatigue, sleep disturbance, 
and attentional functioning among long-term breast cancer survivors (N=1,052).  In addition, 
avoidant coping and self-efficacy for symptom management were examined as potential 
mediators of these relationships.  
Methods: Long-term breast cancer survivors (mean years since diagnosis=6) completed 
questionnaires assessing social constraints from partners and HCPs, avoidant coping, self-
efficacy for symptom management, and symptoms (i.e., fatigue, sleep disturbance, attentional 
functioning).  Structural equation modeling was used to evaluate the hypothesized relationships 
among variables in two models: one focused on social constraints from partners and one focused 
on social constraints from HCPs. 
Results: Both models demonstrated good fit.  Consistent with theory and prior research, greater 
social constraints from both partners and HCPs were associated with greater symptom burden 
(i.e., greater fatigue and sleep disturbance, poorer attentional functioning).  In addition, all 
relationships were mediated by avoidant coping and self-efficacy for symptom management.   
Conclusions:  Findings are consistent with social cognitive processing theory and suggest that 
symptom management interventions may be enhanced by addressing the impact of social 
constraints from survivors’ partners and HCPs on their coping and self-efficacy.    
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Background 
Many breast cancer survivors experience unwanted changes in their relationships 
following diagnosis and treatment [1].  For instance, survivors’ loved ones may act in a nervous 
or uncomfortable manner around them or even avoid them altogether because they do not know 
how to support them [2].  When breast cancer survivors feel unable to disclose their cancer-
related thoughts and feelings because of others’ behavior (e.g., avoidance, criticism), they are 
experiencing social constraints [1].  Unfortunately, constraints from loved ones are associated 
with worse mental health outcomes in breast cancer survivors, including greater depressive 
symptoms, anxiety, and posttraumatic stress disorder (PTSD) symptoms as well as poorer quality 
of life [3,4].   
Social cognitive processing theory (SCPT) provides a framework for understanding the 
relationship between social constraints and mental health outcomes [5].  Specifically, SCPT 
posits that a socially constraining environment impedes psychological adjustment by preventing 
successful cognitive and emotional processing of new information regarding a stressor [1,5].  
Thus, SCPT suggests that social constraints negatively impact cancer survivors’ psychological 
adjustment by decreasing opportunities to engage in healthy processing of cancer-related 
concerns with others.  Prior research with breast and other cancer survivors supports this theory 
[1,3,6].  For example, studies suggest that social constraints may increase cancer survivors’ use 
of avoidant coping strategies (e.g., ignoring stressors), which, in turn, is associated with poorer 
mental health outcomes [6-9].  Furthermore, social constraints have been found to impact breast 
cancer survivors’ mental health by reducing their self-efficacy or confidence for coping with 
cancer-related stress [8].  
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Limited evidence suggests that social constraints from loved ones may also negatively 
affect breast and other cancer survivors’ physical health outcomes.  Specifically, among cancer 
survivors, greater social constraints have been related to poorer physical quality of life [4,10,11] 
and greater self-reported physical impairment [12,13].  However, to our knowledge, research has 
not examined relationships between social constraints and common physical symptoms, 
including fatigue, sleep disturbance, and poor cognitive functioning, in cancer or other medical 
populations.  These symptoms are a major source of suffering, impairment, and disability in 
long-term breast cancer survivors [14-16].  Additionally, research has not examined relationships 
between constraints from health care providers (HCPs) and physical or mental health outcomes 
in cancer or other medical populations.   
Theory and prior research linking social constraints to avoidant coping and self-efficacy 
suggest that social constraints could impact survivors’ physical symptoms [1,5-9,17].  
Specifically, SCPT predicts that survivors experiencing constraints in discussing their illness 
with HCPs or loved ones may avoid managing their symptoms, which could lead to greater 
symptom burden [1,5].  For example, if a breast cancer survivor believes her HCP minimized her 
concerns about treatment-related changes in cognitive functioning, she may avoid discussing 
cognitive changes with her HCP in the future.  As a result, the HCP would not be able to assist 
with managing this symptom.  In addition, greater social constraints have been associated with 
lower coping self-efficacy [8], which may impact symptom burden via decreased engagement in 
symptom management strategies.  This negative relationship between coping self-efficacy and 
symptom burden is consistent with the integrated behavioral model (IBM) [17], which theorizes 
that reduced self-efficacy for behaviors to manage symptoms decreases engagement in those 
behaviors.  Consistent with this theory, research with cancer survivors has found that lower 
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levels of self-efficacy are associated with poorer health behaviors and increased symptom burden 
[18,19].   
Present Study 
The present study investigated relationships between romantic partner and HCP social 
constraints and long-term breast cancer survivors’ fatigue, sleep disturbance, and cognitive 
functioning as well as potential mediators of these relationships.  Whereas prior work has largely 
focused on relationships between partner or family/friend constraints and survivors’ mental 
health outcomes [1], this study examines the impact of both partner and HCP constraints on 
survivors’ physical symptoms.  Identifying these relationships as well as potential mechanisms 
underlying them would inform the development of interventions to reduce breast cancer 
survivors’ symptom burden.  Based on SCPT and limited research linking partner constraints to 
worse global physical health outcomes in cancer survivors [4,5,10-13], we hypothesized that 
greater social constraints from partners and HCPs would be associated with greater fatigue and 
sleep disturbance and poorer attentional functioning in long-term breast cancer survivors.  In 
addition, based on SCPT, IBM, and prior literature [5,8,17], we hypothesized that increased 
avoidant coping and decreased breast cancer self-efficacy (i.e., self-efficacy for managing 
symptoms and quality-of-life problems related to breast cancer) would mediate relationships 
between social constraints and each symptom.   
Methods 
Participants and Procedure 
Long-term breast cancer survivors (N = 1,127) were recruited from the Eastern 
Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-
ACRIN) database of 97 sites as part of a larger, cross-sectional parent study [20].  Descriptions 
Running head: SOCIAL CONSTRAINTS AND CANCER SYMPTOMS         8 
 
of study procedures have been published [20].  Briefly, eligibility criteria included: (1) having 
been diagnosed with early-stage breast cancer (i.e., stages I-IIIA) at age 45 or younger or 
between 55 and 70 years of age; (2) having been treated with a chemotherapy regimen that 
included Adriamycin, Paclitaxel, or Cyclophosphamide; (3) being 3-8 years post-initial 
treatment; and (4) not having a cancer recurrence.  Enrollment was restricted to survivors 
diagnosed at age 45 years or younger to obtain a primarily premenopausal sample at diagnosis as 
well as survivors diagnosed between ages 55 and 70 years to obtain a postmenopausal sample.  
However, at the time of participation, ages ranged from 28-78 years.  Additionally, enrollment 
was restricted to survivors who received certain chemotherapy regimens in order to reduce 
treatment-related variance in symptoms and other outcomes.  
After obtaining institutional review board approval from the coordinating site (a large 
Midwestern university) and all 97 participating ECOG-ACRIN sites, the ECOG-ACRIN office 
contacted the physicians of all eligible survivors.  The physicians obtained permission from 
eligible women to provide their contact information to the coordinating site.  Survivors who gave 
permission were mailed a brochure about the study and called by a research assistant to obtain 
verbal consent.  Of the 1,681 eligible survivors contacted, 1,277 (76%) consented.  
Subsequently, they were mailed the study questionnaire and consent forms to complete at home 
as well as a postage-paid envelope for returning the materials.  A total of 1,127 (88%) returned 
the signed consent form and study questionnaires.  Survivors who completed study 
questionnaires were mailed a $25 check to thank them for their participation.  
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Measures 
Demographic and medical characteristics.  Age, years of education, total household 
income, and marital status were self-reported.  Clinical variables (e.g., disease stage, cancer 
treatments received, and time since diagnosis) were collected from survivors’ medical records.  
Social constraints.  Fourteen items from the Social Constraints Scale [21] were used to 
assess perceptions of social constraints from a romantic partner during the past four weeks.  A 
modified 13-item version of the measure was developed for the current study to assess 
perceptions of social constraints from their HCP during their last visit.  One of the original items 
(“Let you down by not showing enough love”) was removed from the HCP version because it 
was not applicable to providers.  Both measures were found to be unidimensional in exploratory 
factor analyses (results not shown).  Each item was rated on a 4-point scale from 1 (never) to 4 
(often).  A sample item is “Make you feel that you couldn't talk about your breast cancer because 
it made them uncomfortable.”  Composite scores were calculated by summing the items (after 
reverse coding, as necessary), with higher scores indicating greater social constraints from 
partners or HCPs.  The scale for partner social constraints has shown adequate validity and 
internal consistency reliability in studies of breast cancer survivors [3,21].  In this study, internal 
consistency reliabilities were excellent for both the partner social constraints (α=0.91) and HCP 
social constraints (α=0.86) measures.  
Avoidant coping.  Avoidant coping was assessed with a 6-item avoidant coping subscale 
from the Brief COPE [22].  The items were modified to reflect coping with breast cancer.  The 
avoidant coping items were selected by our research group based on the results of confirmatory 
factor analyses with the current study population (Rand et al., unpublished manuscript).  Each 
item was rated on a 4-point scale ranging from 0 (I haven't been doing this at all) to 3 (I've been 
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doing this a lot).  A sample item is “I've been giving up trying to deal with breast cancer.”  Good 
reliability and validity evidence has been reported for the Brief COPE in breast cancer survivors 
[23].  In this study, internal consistency reliability for the avoidant coping subscale was 
acceptable (α=0.69).  
Breast cancer self-efficacy.  Breast cancer self-efficacy was assessed with the 11-item 
Breast Cancer Self-Efficacy Scale [24], which was designed to measure self-efficacy for 
symptom management and coping with quality-of-life problems related to breast cancer.  Each 
item was rated on a 5-point scale from 1 (strongly disagree) to 5 (strongly agree).  Sample items 
include “I am able to deal with physical symptoms from having breast cancer” and “I am able to 
ask for help when I have problems related to my breast cancer.”  The composite score was 
calculated by summing the items, with higher scores indicating greater self-efficacy.  The 
measure was developed as part of the parent study; excellent evidence of validity and internal 
consistency reliability (α=0.89) were obtained in the current sample [24].  
Fatigue.  The 13-item Fatigue subscale of the Functional Assessment of Cancer Therapy 
(FACT) [25] was used to assess survivors’ fatigue.  Each item was rated on a 5-point scale 
ranging from 0 (not at all) to 4 (very much so).  The composite score was calculated by summing 
the items (after reverse-scoring, as necessary), with higher scores indicating greater fatigue. 
Excellent validity and internal consistency reliability evidence is available for the subscale [25]. 
In this study, internal consistency reliability was excellent (α=0.94).  
Sleep disturbance. Sleep disturbance was assessed with the global score of the 19-item 
Pittsburgh Sleep Quality Index (PSQI) [26].  The global score is the sum of all 7 component 
scores.  Total scores range from 0-21, with higher scores indicating greater sleep disturbance.  
The PSQI has demonstrated good validity and reliability across patient populations, including 
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breast cancer patients [26,27].  In this study, internal consistency reliability for the 7 component 
scores was acceptable (α=0.75). 
Cognitive functioning.  Cognitive functioning was assessed with the 16-item total score 
of the Attentional Function Index [28,29].  Each item was rated on a 10-point scale from 0 (not 
at all) to 10 (extremely well).  The composite score was calculated by averaging all of the items, 
with higher scores indicating better attentional functioning.  The Attentional Functioning Index 
has shown excellent validity and reliability among breast cancer patients [28,29].  In this study, 
internal consistency reliability was excellent (α=0.91).  
Statistical Methods 
Descriptive statistics for study variables were computed using SPSS statistical software 
(version 20.0; SPSS, Chicago, IL, USA).  Zero-order correlations between study variables also 
were computed.  Two path models were examined: the first model focused on the impact of 
partner social constraints on physical symptoms (i.e., partner constraints model) and the second 
model focused on the impact of HCP social constraints on these symptoms (i.e., HCP constraints 
model).  The hypothesized path models were tested using structural equation modeling (SEM) 
with bootstrapping and a robust maximum likelihood estimator in Mplus statistical software.  
Full information maximum likelihood data imputation was used to address missing data.  
Endogenous variables (i.e., mediators and dependent variables) in both models included avoidant 
coping, breast cancer self-efficacy, fatigue, sleep disturbance, and attentional functioning.  The 
error variances of the endogenous variables were allowed to correlate.  Exogenous variables (i.e., 
independent variables and covariates) included social constraints (i.e., partner social constraints 
in one model and HCP social constraints in the other model) and demographic and medical 
factors (i.e., age, years of education, income, marital status, and time since diagnosis).  The 
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symptom outcomes were regressed on social constraints and demographic and medical factors, 
whereas the mediators (i.e., avoidant coping, breast cancer self-efficacy) were only regressed on 
social constraints.  The demographic and medical covariates included in the models were 
selected based on significant associations (p<0.05) with at least one study variable in preliminary 
analyses.  The final sample sizes for the partner and HCP models were 802 and 1,052, 
respectively.  
To evaluate the models’ fit, we examined the goodness-of-fit χ2 statistics, the root mean 
square error of approximation (RMSEA) statistics, the comparative fit indices (CFI), and the 
standardized root mean square residual (SRMR) statistics.  Adequate model fit was defined as: 
(1) a non-significant χ2 statistic indicating no difference between the modeled and observed 
patterns of relationships; (2) RMSEA <0.06; (3) CFI >0.95; and (4) SRMR<.08, as suggested by 
Hu and Bentler [30].  The correlation matrices were based on all available data.  The final 
models for our data, excluding demographic and medical covariates, are shown in Figures 1a 
(partner constraints model) and 1b (HCP constraints model).  The only differences between the 
initial hypothesized models and the final models were that modification indices suggested adding 
paths between some of the demographic and medical covariates and certain mediators.  These 
paths were added because they were also conceptually relevant.  Specifically, in the partner 
constraints model, paths from age to both mediators, education to breast cancer self-efficacy, and 
income to avoidant coping were added.  In addition, in the HCP constraints model, paths from 
age to both mediators, education to breast cancer self-efficacy, and income to both mediators 
were added.  The final partner constraints model included 25 pathways and the final HCP 
constraints model included 24 pathways.  
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Results 
Descriptive Statistics 
As shown in Table 1, breast cancer survivors were primarily Caucasian (92%) and 
married (74%) with a mean age of 57 years (SD=12.0 years).  Forty-one percent of survivors’ 
household incomes fell between $30,000 and $75,000 with a broad range that represented the 
entire scale.  On average, survivors had completed 14.5 years of education (SD=2.7 years).  The 
average time since the breast cancer diagnosis was 5.9 years (SD=1.5 years).  On average, 
participants reported low levels of both partner (M=21.0, SD=8.0) and HCP (M=15.3, SD=4.2) 
social constraints.  Partner and HCP social constraints were moderately correlated (r=0.33, 
p<0.001).  On average, survivors reported having fatigue (M=40.0, SD=10.1), which was 
comparable to that found in prior literature with long-term breast cancer survivors [31].  On 
average, survivors’ reported high levels of sleep disturbance (M=6.4, SD=3.7), consistent with 
prior studies of breast cancer survivors [15].  Lastly, the average score on the Attentional 
Functioning Index (M=6.9, SD=1.8) was comparable to that found in prior research with breast 
cancer survivors [29].  Zero-order correlations between all study variables are found in online 
supporting information 1.   
Main Findings 
Figure 1a shows the results for the partner constraints model, adjusted for demographic 
and medical covariates.  The final modified model showed excellent fit as determined by the 
non-significant χ2 statistic (χ2=7.86, df=6, p=0.25) and goodness of fit indices (i.e., 
RMSEA=0.02, CFI=1.00, and SRMR=.01).  As hypothesized, greater partner social constraints 
were associated with greater fatigue (β=0.10, p=0.017), greater sleep disturbance (β=0.10, 
p=0.011), and poorer cognitive functioning (β=-0.08, p=0.040).  In addition, both avoidant 
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coping and breast cancer self-efficacy mediated relationships between partner social constraints 
and each symptom (see Table 2 for indirect effects).  Specifically, higher levels of partner social 
constraints were associated with more avoidant coping (β=0.42, p<0.0001), which in turn was 
associated with greater fatigue (β=0.17, p<0.0001), greater sleep disturbance (β=0.10, p=0.016), 
and poorer attentional functioning (β=-0.15, p<0.0001).  Furthermore, higher levels of partner 
social constraints were associated with reduced breast cancer self-efficacy (β=-0.38, p<0.0001), 
which in turn was associated with greater fatigue (β=-0.27, p<0.0001), greater sleep disturbance 
(β =-0.25, p<0.0001), and poorer attentional functioning (β=0.33, p<0.0001).  Parameter 
estimates for relationships between demographic and medical covariates and endogenous study 
variables in the partner constraints model are found in online supporting information 2.  
Figure 1b shows the results for the HCP constraints model, adjusted for demographic and 
medical covariates.  The final modified model showed excellent fit as determined by the non-
significant χ2 statistic (χ2=1.93, df=5, p=0.86) and goodness of fit indices (i.e., RMSEA=0.00, 
CFI =1.00, and SRMR=.01).  As hypothesized, higher levels of HCP social constraints were 
associated with greater fatigue (β=0.13, p<0.0001), greater sleep disturbance (β=0.10, p=0.003), 
and poorer attentional functioning (β=-0.07, p=0.010).  In addition, both avoidant coping and 
breast cancer self-efficacy mediated relationships between HCP social constraints and each 
symptom (see Table 3 for total indirect effects).  Specifically, higher levels of HCP social 
constraints were associated with more avoidant coping (β=0.26, p<0.0001), which in turn was 
associated with greater fatigue (β=0.17, p<0.0001), greater sleep disturbance (β=0.13, p<0.0001), 
and poorer attentional functioning (β=-0.15, p<0.0001).  Furthermore, higher levels of HCP 
social constraints were associated with reduced breast cancer self-efficacy (β=-0.28, p<0.0001), 
which in turn was associated with greater fatigue (β=-0.25, p<0.0001), greater sleep disturbance 
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(β =-0.24, p<0.0001), and poorer attentional functioning (β=0.33, p<0.0001).  Parameter 
estimates for relationships between demographic and medical covariates and endogenous study 
variables in the HCP constraints model are found in online supporting information 3.  
Conclusions 
As hypothesized, greater social constraints from partners and HCPs were associated with 
higher levels of fatigue and sleep disturbance and poorer attentional functioning among long-
term breast cancer survivors.  Whereas prior research has linked increased partner social 
constraints to worse global physical health in cancer survivors [4,10-13], this is the first study to 
find relationships between both partner and HCP social constraints and highly prevalent and 
disabling physical symptoms in breast cancer survivors.  Furthermore, results suggest that 
increased avoidant coping and reduced self-efficacy for symptom management account for 
relationships between partner and HCP social constraints and physical symptoms.  These 
findings support hypotheses derived from SCPT and the IBM and extend prior research linking 
increased partner social constraints to greater avoidant coping and reduced coping self-efficacy 
in cancer survivors [5-9], as well as research linking avoidant coping and self-efficacy for 
symptom management to survivors’ symptoms [17,18,32].  
Although our findings are consistent with theory, alternative explanations for the results 
may be considered.  For instance, although we hypothesized that social constraints contribute to 
lower self-efficacy, greater avoidant coping, and greater symptom burden, it is possible that these 
factors and related constructs (e.g., distress) lead to greater social constraints.  Specifically, a 
breast cancer survivor who avoids managing stressors and feels less confident in her problem-
solving abilities may perceive others as more critical or elicit more critical responses from 
others.  Additionally, fatigue, sleep disturbance, and attentional functioning are common 
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symptoms of depression, and a depressed individual may elicit more negative interactions from 
others [33-35].  Longitudinal research is needed to explore the direction of these relationships.  
In addition, alternative behavioral, psychological, and physiological mechanisms underlying 
relations between social constraints and physical symptoms warrant exploration.  For example, 
poorer health behaviors may help explain relationships between social constraints and symptoms, 
as a socially constraining environment may affect determinants of these behaviors (e.g., self-
efficacy, coping processes).  Loneliness is another potential mediator of the relationship between 
social constraints and symptoms that deserves examination.  Theory and prior research suggest 
that social constraints are associated with survivors’ feelings of loneliness [5,36].  Furthermore, 
loneliness has been associated with reduced immune functioning, which in turn has predicted 
greater symptom burden among breast cancer survivors [37].   
This study has important implications for future intervention research.  Findings suggest 
that reducing HCP and partner social constraints may decrease breast cancer survivors’ symptom 
burden, yet social constraints have not been studied as an intervention outcome in the cancer 
literature.  To date, couple-based interventions to improve communication skills have shown 
positive effects on other relational outcomes in breast cancer survivors [38].  In addition, 
interventions to improve breast cancer survivors’ assertive communication with medical 
providers, which is likely hindered in socially constraining HCP interactions, have been found to 
decrease their post-treatment symptom burden [39].  Further research is needed to examine 
whether such intervention approaches may also impact social constraints. 
The present findings also suggest that interventions targeting survivors’ use of avoidant 
coping and their self-efficacy for symptom management may mitigate the negative impact of 
social constraints on their symptom burden.  A number of efficacious interventions have focused 
Running head: SOCIAL CONSTRAINTS AND CANCER SYMPTOMS         17 
 
on improving breast cancer survivors’ coping skills and self-efficacy for behavior changes (e.g., 
exercise) that are related to their symptom burden [40,41].  But these intervention trials have not 
been conducted within a SCPT framework that would address the impact of the socially 
constraining environment on survivors’ coping skills and self-efficacy.  Specifically, 
psychosocial interventions have tended to focus on increasing positive social interactions (e.g., 
social support) rather than decreasing negative social interactions (e.g., social constraints), 
although theory and research suggest that negative social interactions may have a greater impact 
on health outcomes than positive social interactions [42].  Further, symptom management 
interventions for cancer survivors have rarely targeted social interactions [39].  Reducing 
negative social interactions, such as criticism, between survivors and their partners and HCPs 
would be a novel intervention approach.   
Limitations of this study and directions for future research should be noted.  First, the 
sample primarily consisted of Caucasian, middle-class women.  Future studies should include 
survivors with greater diversity with respect to demographic characteristics.  Second, the main 
study variables were self-reported; future research may include behavioral or observer 
assessments of study variables.  For instance, social constraints are defined as both objective and 
subjective experiences (i.e., others’ behaviors and survivors’ interpretations of them) [1].  
Assessing social constraints by recording and coding social interactions as positive, neutral, or 
negative is rarely done [44] and might yield different results.  Finally, the cross-sectional design 
precluded an examination of directionality, and a limited number of mediators and outcomes 
were examined.  Longitudinal research is needed to investigate processes through which social 
constraints may impact a range of physical health outcomes in breast cancer survivors. 
Running head: SOCIAL CONSTRAINTS AND CANCER SYMPTOMS         18 
 
The current findings have implications for clinical practice with breast cancer survivors.  
Specifically, findings suggest that HCPs’ communication style may impact patients’ symptom 
management; thus, HCPs should communicate in a manner that validates patients’ thoughts and 
feelings and increases their self-confidence for symptom management.  For example, HCPs 
could use motivational interviewing, an empathic, evidence-based method of interacting with 
patients that aims to enhance health behavior change (e.g., symptom management) [43].  
Motivational interviewing addresses two factors in this study (i.e., greater avoidant coping, 
decreased self-efficacy) that accounted for relationships between social constraints and physical 
symptoms.  HCPs may also assess patients’ satisfaction with their support network.  If patients 
report distress related to social constraints, referral to individual, couple, or family counseling 
may be warranted.  Additionally, HCPs could provide educational materials to partners and 
family members that include communication tips.  Furthermore, practitioners providing 
psychotherapy should be attentive to patient reports of negative social interactions with HCPs 
and family members and intervene by promoting open, empathic communication.  Consideration 
of social factors contributing to suboptimal symptom management among long-term breast 
cancer survivors may be key to reducing their symptom burden.  
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Table 1. Sample characteristics (N = 1,127) 
 
  
Characteristic n (%) M (SD) Range 
Average age (years) 
 
 57.1 (11.6) 28.0-78.0 
Race/ethnicity 
  Caucasian 
  Black or African American 
  Other 
  Asian 
  American Indian or Alaskan Native 
 
 
1041 (92.4) 
    43 (3.8) 
    32 (2.8) 
      4 (0.9) 
      1 (0.1) 
  
Marital status 
  Married 
  Widowed   
  Single 
  Divorced 
  Missing 
 
 
  836 (74.2) 
  104 (9.2) 
    89 (7.9) 
    80 (7.1) 
    18 (1.6) 
  
Average years of education  
(n = 1,115) 
 
 14.5 (2.7) 7.0-20.0 
Annual Household Income 
  <$30,000 
  $30,000 to $75,000 
  >$75,000 to $150,000 
  >$150,000 
  Don’t know or missing 
 
 
  194 (17.2) 
  457 (40.5) 
  325 (28.8) 
  113 (10.0) 
    38 (3.4) 
  
Average years since diagnosis  5.9 (1.5) 3.0-9.0 
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Table 2. Indirect effects from partner social constraints to symptoms   
 Effect  
 Z statistic p-value 95% CI 
 
Partner social constraints to fatigue 
   
Total indirect 0.17 <0.0001  0.13 to 0.21 
Partner social constraints  avoidant coping  fatigue 0.07 <0.0001  0.04 to 0.10 
Partner social constraints  self-efficacy  fatigue 0.10 <0.0001  0.07 to 0.13 
 
Partner social constraints to sleep disturbance 
   
Total indirect  0.14 <0.0001  0.10 to 0.18 
Partner social constraints  avoidant coping  sleep 
disturbance 
 0.04   0.018  0.01 to 0.08 
Partner social constraints  self-efficacy  sleep 
disturbance 
 0.09 <0.0001  0.06 to 0.12 
 
Partner social constraints to attentional functioning 
   
Total indirect -0.19 <0.0001 -0.23 to -0.15 
Partner social constraints  avoidant coping  
attentional functioning 
-0.06   0.001 -0.10 to -0.03 
Partner social constraints  self-efficacy  attentional 
functioning 
-0.13 <0.0001 -0.16 to -0.10 
Note. N = 802.  95% CI = 95% confidence interval.  
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Table 3. Indirect effects from health care provider social constraints to symptoms  
 Effect  
 Z statistic p-value 95% CI 
 
HCP social constraints to fatigue 
   
Total indirect 0.11 <0.0001  0.09 to 0.14 
HCP social constraints  avoidant coping  fatigue 0.04 0.001 0.03 to 0.06 
HCP social constraints  self-efficacy  fatigue 0.07 <0.0001 0.05 to 0.09 
 
HCP social constraints to sleep disturbance 
   
Total indirect  0.10 <0.0001 0.08 to 0.13 
HCP social constraints  avoidant coping  sleep 
disturbance 
 0.04 0.003 0.02 to 0.05 
HCP social constraints  self-efficacy  sleep disturbance  0.07 <0.0001 0.04 to 0.09 
 
HCP social constraints to attentional functioning 
   
Total indirect -0.13 <0.0001 -0.16 to -0.10 
HCP social constraints  avoidant coping  attentional 
functioning 
-0.04 0.001 -0.06 to -0.02 
HCP social constraints  self-efficacy  attentional 
functioning 
-0.09 <0.0001 -0.12 to -0.07 
Note. N = 1,052. HCP = health care provider.  95% CI = 95% confidence interval 
 
 
 
 
 
 
 
 
 
 
Figure 1. Final mediation models 
 
  
 
Note. Standardized coefficients for the final model.  All paths are statistically significant. HCP = 
health care provider.  Select demographic and medical factors were also included: age, 
education, income, time since diagnosis, and marital status.  Specifically, in Figure 1a, there are 
paths from age to avoidant coping, self-efficacy, and each symptom.  In addition, in Figure 1a, 
there are paths from education to self-efficacy and each symptom.  Finally, in Figure 1a, there 
are paths from income to avoidant coping and each symptom.  In Figure 1b, there are paths from 
age to avoidant coping, self-efficacy, and each symptom.  In addition, in Figure 1b, there are 
paths from education to self-efficacy and each symptom. Finally, in Figure 1b, there are paths 
from income to avoidant coping, self-efficacy, and each symptom. Parameter estimates for these 
pathways are included in online supporting information 2 and 3.  
 
 
Online Supporting Information 1 
 
Zero-order correlations among variables in the partner constraints model 
 
Study Variable 1 2 3 4 5 6 7 8 9 10 11 
 
1. Partner social constraints 
 
—           
2. Avoidant coping 
 
 0.43 —          
3. Self-efficacy 
 
-0.40 -0.46 —         
4. Fatigue 
 
 0.29  0.36 -0.41 —        
5. Sleep disturbance 
 
 0.25  0.28 -0.35  0.56 —       
6. Attentional functioning 
 
-0.29 -0.37  0.47 -0.69 -0.47 —      
7. Age 
 
-0.12 -0.16  0.19 -0.12 -0.09  0.21 —     
8. Years of education 
 
-0.02 -0.02  0.10 -0.10 -0.13  0.12 -0.16 —    
9. Income 
 
 0.02  0.09 -0.06  0.11  0.10 -0.08  0.27 -0.31 —   
10. Marital statusa 
 
-0.02 -0.08  0.04 -0.06 -0.05  0.14  0.06  0.04 -0.12 —  
11. Time since diagnosis -0.00 -0.05  0.05 -0.08 -0.09  0.06  0.15  0.01  0.01 -0.01 — 
 
Note. N = 802. The zero-order correlations were estimated with bootstrapping and a robust maximum likelihood estimator in Mplus 
statistical software.  
aCoded (currently married = 1, not currently married= 0). 
 
 
Zero-order correlations among variables in the health care provider constraints model 
 
Study Variable 1 2 3 4 5 6 7 8 9 10 11 
 
1. HCP social constraints 
 
—           
2. Avoidant coping 
 
 0.28 —          
3. Self-efficacy 
 
-0.30 -0.44 —         
4. Fatigue 
 
 0.26  0.33 -0.39 —        
5. Sleep disturbance 
 
 0.21  0.28 -0.35  0.57 —       
6. Attentional functioning 
 
-0.23 -0.34  0.46 -0.68 -0.47 —      
7. Age 
 
-0.14 -0.15  0.17 -0.12 -0.09  0.17 —     
8. Years of education 
 
 0.03 -0.00  0.11 -0.09 -0.12  0.13 -0.15 —    
9. Income 
 
-0.03  0.07 -0.06  0.12  0.13 -0.09  0.30 -0.32 —   
10. Marital statusa 
 
 0.07 -0.02 -0.02 -0.00 -0.03  0.02 -0.17  0.01 -0.39 —  
11. Time since diagnosis -0.03 -0.06  0.04 -0.07 -0.07  0.06  0.16 -0.01  0.03 -0.07 — 
 
Note. N = 1052. HCP = health care provider. The zero-order correlations were estimated with bootstrapping and a robust maximum 
likelihood estimator in Mplus statistical software.  
aCoded (currently married = 1, not currently married= 0). 
 
 
 
Online Supporting Information 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. N = 802. 
aCoded (currently married = 1, not currently married= 0). 
 
 
Parameter estimates for demographic and medical covariates in the partner constraints model 
 
 Avoidant 
coping 
Breast cancer 
self-efficacy 
 
Fatigue 
Sleep 
disturbance 
Attentional 
functioning 
Characteristic β p β p β p β p β p 
Age -0.13 <0.0001  0.16 <0.0001 -0.05 0.227 -0.03 0.381 0.13 0.001 
 
Years of 
education 
 
— 
 
— 
  
 0.12 
 
<0.0001 
 
-0.05 
 
0.192 
 
-0.09 
 
0.013 
 
0.09 
 
0.008 
 
Income 
 
0.10 
 
0.005 
 
— 
 
— 
 
0.07 
 
0.040 
  
 0.06 
 
0.131 
 
-0.04 
 
0.244 
 
Marital statusa 
 
— 
 
— 
 
— 
 
— 
 
-0.02 
 
0.432 
 
-0.02 
 
0.644 
 
0.10 
 
0.021 
 
Time since 
diagnosis 
 
— 
 
— 
 
— 
 
— 
 
-0.05 
 
0.119 
 
-0.07 
 
0.041 
 
0.02 
 
0.552 
Online Supporting Information 3 
Parameter estimates for demographic and medical covariates in the health care provider constraints model 
 Avoidant 
coping 
Breast cancer 
self-efficacy 
 
Fatigue 
Sleep 
disturbance 
Attentional 
functioning 
 
Characteristic 
 
β 
 
p 
 
β 
 
p 
 
β 
 
p 
 
β 
 
p 
 
β 
 
p 
 
Age 
 
-0.15 
 
<0.0001 
   
 0.17 
 
<0.0001 
 
-0.06 
  
  0.031 
 
-0.05 
  
 0.151 
  
 0.12 
 
<0.0001 
 
Years of 
education 
 
 
— 
 
 
— 
  
 
 0.12 
 
 
<0.0001 
 
 
-0.04 
 
  
  0.176 
 
 
-0.07 
 
  
 0.024 
  
  
 0.09 
  
   
  0.002 
 
Income 
  
 0.12 
  
<0.0001 
 
-0.07 
 
  0.021 
  
 0.12 
 
<0.0001 
  
 0.10 
 
 0.002 
 
-0.06 
  
  0.051 
 
Marital statusa 
 
— 
 
— 
 
— 
 
— 
 
 0.02 
  
  0.550 
 
-0.01 
 
 0.886 
  
 0.03 
  
  0.409 
 
Time since 
diagnosis 
 
 
— 
 
 
— 
 
 
— 
 
 
— 
  
 
-0.04 
  
   
  0.174 
 
 
-0.05 
 
  
 0.131 
  
  
 0.02 
  
   
  0.423 
Note. N = 1052. 
aCoded (currently married = 1, not currently married= 0). 
 
